Quality of care in patients with inflammatory bowel disease from a public health center in Brazil

Table 2 Clinical characteristics of patients with Crohn’s disease and ulcerative colitis

	IBD (n = 133)	Crohn’s disease (n = 69)	Ulcerative colitis (n = 64)	P value1
Time since diagnosis (years)	8.44 ± 7.59	9.64 ± 9.02	7.14 ± 5.45	0.0171
Disease extent, n (%)
Proctitis			13 (20.31)
Left-sided colitis			17 (26.56)
Extensive/Pancolitis			34 (53.13)
Montreal classification
Age at diagnosis, n (%)
A1 (< 17 years)		16 (23.19)
A2 (17-40 years)		46 (66.67)
A3 (> 40 years)		7 (10.14)
Disease location, n (%)
L1 (ileal)		16 (23.19)
L2 (colonic)		9 (13.04)
L3 (ileocolonic)		44 (63.77)
Disease behavior, n (%)
B1 (non-stricturing, non-penetrating)		24 (34.78)
B2 (stricturing)		25 (36.23)
B3 (penetrating)		20 (28.99)
Perianal disease, n (%)		28 (40.58)
Disease activity, n (%)
Remission		43 (62.32)	45 (70.31)
Mild		13 (18.84)	1 (1.56)
Moderate		10 (14.49)	13 (20.31)
Severe		3 (4.35)	5 (7.81)
Partial Mayo score (points)			2.14 ± 2.72
CDAI score (points)		140.63 ± 112.48
Medications in use, n (%)
Mesalazine	31 (23.31)	1 (1.45)	30 (46.88)	< 0.0001
Azathioprine	65 (48.87)	42 (60.87)	23 (35.94)	0.0041
Corticosteroid	9 (6.77)	3 (4.35)	6 (9.38)	0.2488
Infliximab	45 (33.83)	31 (44.93)	14 (21.88)	0.0050
Adalimumab	20 (15.04)	14 (20.29)	6 (9.38)	0.0785
Certolizumabe pegol	1 (0.75)	1 (1.45)	-	-
No medication	4 (3.01)	2 (2.90)	2 (3.13)	1.0000
Previous hospitalization, n (%)	31 (23.31)	47 (68.12)	30 (46.88)	0.0132
Number of previous hospitalizations	0.79 ± 1.24	1.02 ± 1.46	0.55 ± 0.91	0.0061
Previous surgery, n (%)	44 (33.08)	37 (53.62)	7 (10.94)	< 0.0001
Number of previous surgeries	0.56 ± 1.19	0.98 ± 1.50	0.14 ± 0.50	< 0.0001
Presence of ostomy, n (%)	14 (10.53)	11 (15.94)	3 (4.69)	0.0471

¹P value (Crohn’s disease vs ulcerative colitis).

Data are expressed as mean ± SD or frequency (proportion). IBD: Inflammatory bowel disease; CDAI: Crohn’s disease activity index.